[Cryptococcosis].
Miyazaki
Yoshitsugu
Y
Second Department of Internal Medicine, Nagasaki University School of Medicine.
Kohno
Shigeru
S
D000666:Amphotericin B / Q000008:administration & dosage; D000818:Animals; D003453:Cryptococcosis / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003455:Cryptococcus neoformans / Q000472:pathogenicity; D003937:Diagnosis, Differential; D015725:Fluconazole / Q000008:administration & dosage; D006801:Humans; D007111:Immunity, Cellular; D016867:Immunocompromised Host; D008543:Melanins; D011134:Polysaccharides; D011379:Prognosis; D037521:Virulence Factors
D008543:Melanins; D011134:Polysaccharides; D037521:Virulence Factors; D000666:Amphotericin B; D015725:Fluconazole